Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services - PubMed (original) (raw)
Review
Drug safety in pregnancy: utopia or achievable prospect? Risk information, risk research and advocacy in Teratology Information Services
Christof Schaefer. Congenit Anom (Kyoto). 2011 Mar.
Abstract
Even though from preclinical testing to drug risk labeling, the situation with drugs in pregnancy has improved substantially since the thalidomide scandal, there is still an increasing need to provide healthcare professionals and patients with updated individualized risk information for clinical decision making. For the majority of drugs, clinical experience is still insufficient with respect to their safety in pregnancy. There is often uncertainty in how to interpret the available scientific data. Based on 20 years of experience with Teratology Information Services (TIS) cooperating in the European Network of Teratology Information Services (ENTIS) methods of risk interpretation, follow-up of exposed pregnancies through the consultation process and their evaluation is discussed. Vitamin K antagonists, isotretinoin and angiotensin (AT) II-receptor-antagonists are presented as examples of misinterpretation of drug risks and subjects of research based on observational clinical data recorded in TIS. As many TIS are poorly funded, advocacy is necessary by establishing contacts with decision makers in health politics and administration, informing them of the high return in terms of health outcomes and cost savings provided by TIS as reference institutions in clinical teratology.
© 2011 The Author. Congenital Anomalies © 2011 Japanese Teratology Society.
Similar articles
- The effectiveness of Teratology Information Services (TIS).
Hancock RL, Koren G, Einarson A, Ungar WJ. Hancock RL, et al. Reprod Toxicol. 2007 Feb;23(2):125-32. doi: 10.1016/j.reprotox.2006.11.005. Epub 2006 Nov 18. Reprod Toxicol. 2007. PMID: 17184969 Review. - Post-marketing surveillance system for drugs in pregnancy--15 years experience of ENTIS.
Schaefer C, Hannemann D, Meister R. Schaefer C, et al. Reprod Toxicol. 2005 Sep-Oct;20(3):331-43. doi: 10.1016/j.reprotox.2005.03.012. Reprod Toxicol. 2005. PMID: 15978773 Review. - Providing information regarding exposures in pregnancy: a survey of North American Teratology Information Services.
Hancock RL, Ungar WJ, Einarson A, Goodstadt M, Koren G. Hancock RL, et al. Reprod Toxicol. 2008 Apr;25(3):381-7. doi: 10.1016/j.reprotox.2008.02.005. Epub 2008 Mar 2. Reprod Toxicol. 2008. PMID: 18423962 - Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.
Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C. Schaefer C, et al. Reprod Toxicol. 2008 Sep;26(1):36-41. doi: 10.1016/j.reprotox.2008.05.064. Epub 2008 Jun 7. Reprod Toxicol. 2008. PMID: 18588969 - Vitamin K antagonists and pregnancy outcome. A multi-centre prospective study.
Schaefer C, Hannemann D, Meister R, Eléfant E, Paulus W, Vial T, Reuvers M, Robert-Gnansia E, Arnon J, De Santis M, Clementi M, Rodriguez-Pinilla E, Dolivo A, Merlob P. Schaefer C, et al. Thromb Haemost. 2006 Jun;95(6):949-57. doi: 10.1160/TH06-02-0108. Thromb Haemost. 2006. PMID: 16732373
Cited by
- Development and evaluation of an algorithm to link mothers and infants in two US commercial healthcare claims databases for pharmacoepidemiology research.
Weaver J, Hardin JH, Blacketer C, Krumme AA, Jacobson MH, Ryan PB. Weaver J, et al. BMC Med Res Methodol. 2023 Oct 21;23(1):246. doi: 10.1186/s12874-023-02073-6. BMC Med Res Methodol. 2023. PMID: 37865728 Free PMC article. - Toxicology knowledge graph for structural birth defects.
Evangelista JE, Clarke DJB, Xie Z, Marino GB, Utti V, Jenkins SL, Ahooyi TM, Bologa CG, Yang JJ, Binder JL, Kumar P, Lambert CG, Grethe JS, Wenger E, Taylor D, Oprea TI, de Bono B, Ma'ayan A. Evangelista JE, et al. Commun Med (Lond). 2023 Jul 17;3(1):98. doi: 10.1038/s43856-023-00329-2. Commun Med (Lond). 2023. PMID: 37460679 Free PMC article. - Transfer of anticonvulsants and lithium into amniotic fluid, umbilical cord blood & breast milk: A systematic review & combined analysis.
Schmidt CT, Deligiannidis KM, Kittel-Schneider S, Frodl T, Spigset O, Paulzen M, Schoretsanitis G. Schmidt CT, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Jun 8;124:110733. doi: 10.1016/j.pnpbp.2023.110733. Epub 2023 Feb 15. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 36805301 Free PMC article. - Conditional Independence Test of Failure and Truncation Times: Essential Tool for Method Selection.
Ning J, Pak D, Zhu H, Qin J. Ning J, et al. Comput Stat Data Anal. 2022 Apr;168:107402. doi: 10.1016/j.csda.2021.107402. Epub 2021 Nov 19. Comput Stat Data Anal. 2022. PMID: 34898770 Free PMC article. - Protocol of a prospective and multicentre China Teratology Birth Cohort (CTBC): association of maternal drug exposure during pregnancy with adverse pregnancy outcomes.
Zhou Y, Tao J, Wang K, Deng K, Wang Y, Zhao J, Chen C, Wu T, Zhou J, Zhu J, Li X. Zhou Y, et al. BMC Pregnancy Childbirth. 2021 Sep 1;21(1):593. doi: 10.1186/s12884-021-04073-0. BMC Pregnancy Childbirth. 2021. PMID: 34470618 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials